|
US2018002439A1
|
|
Anti-mesothelin antibodies and uses thereof
|
|
WO2017207545A1
|
|
Molecular signature of hepatocellular carcinoma
|
|
WO2017202994A1
|
|
Method for predicting obesity related disease using images of the subcutaneous adipose tissue or the epididymal adipose tissue
|
|
WO2017198849A1
|
|
Derivatives of limonoids for treating and/or preventing growth of breast cancer cells
|
|
WO2017198704A1
|
|
Yif1b for the diagnosis, prevention and / or treatment of ciliopathies
|
|
WO2017191214A1
|
|
Cd31shed as a molecular target for imaging of inflammation
|
|
WO2017194995A1
|
|
A method for determining the temporal progression of a biological phenomenon and associated methods and devices
|
|
US2018021302A1
|
|
Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus
|
